by Lance Smith | Mar 30, 2020 | Study Scavenger Clinical Trial Recruitment Platform
Atlanta, GA – Emory Healthcare announced that its Vaccine and Treatment Evaluation Unit will be a part of clinical testing a COVID-19 vaccine. “The goals of the Phase I study, which began on March 16 at the VTEU at the Kaiser Permanente Washington Health Research...by Lance Smith | Mar 30, 2020 | Study Scavenger Clinical Trial Recruitment Platform
CAMBRIDGE, Mass. & BOULDER, Colo.–(BUSINESS WIRE)–Mar. 27, 2020– AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced the discontinuation of their CyFi-2 study, a randomized Phase 2 clinical study evaluating ficlatuzumab, AVEO’s potent...by Lance Smith | Mar 30, 2020 | Study Scavenger Clinical Trial Recruitment Platform
Dublin, March 27, 2020 (GLOBE NEWSWIRE) — The “Market Spotlight: Acne (2020)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Acne market, comprising key marketed and pipeline drugs, recent...by Lance Smith | Mar 30, 2020 | Study Scavenger Clinical Trial Recruitment Platform
ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity Company’s expertise, infrastructure and flexibility enable remote ECG assessment for fast-tracked COVID-19 vaccines /therapies and other critical pharmaceuticals PHILADELPHIA – March 30, 2020...by Lance Smith | Mar 30, 2020 | Study Scavenger Clinical Trial Recruitment Platform
The University of Alabama at Birmingham will take part in an NIH-sponsored global clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19. The drug remdesivir is the first agent to be...